Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1.
Epstein-Barr virus (EBV) has developed effective strategies to evade host innate immune responses. Here we reported on mitigation of type I interferon (IFN) production by EBV deubiquitinase (DUB) BPLF1 through cGAS-STING and RIG-I-MAVS pathways. The two naturally occurring forms of BPLF1 exerted pot...
Main Authors: | Wai-Yin Lui, Aradhana Bharti, Nok-Hei Mickey Wong, Sonia Jangra, Michael G Botelho, Kit-San Yuen, Dong-Yan Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-02-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1011186 |
Similar Items
-
Epstein–Barr Virus and Innate Immunity: Friends or Foes?
by: Sonia Jangra, et al.
Published: (2019-06-01) -
Interferon Antagonism of Epstein–Barr Virus Tegument Proteins
by: Wai-Yan Lui, et al.
Published: (2020-06-01) -
The Epstein-Barr virus deubiquitinating enzyme BPLF1 regulates the activity of topoisomerase II during productive infection.
by: Jinlin Li, et al.
Published: (2021-09-01) -
Knockout of Epstein-Barr Virus BPLF1 Retards B-Cell Transformation and Lymphoma Formation in Humanized Mice
by: Christopher B. Whitehurst, et al.
Published: (2015-10-01) -
The Epstein-Barr Virus Immunoevasins BCRF1 and BPLF1 Are Expressed by a Mechanism Independent of the Canonical Late Pre-initiation Complex.
by: Jessica McKenzie, et al.
Published: (2016-11-01)